132 related articles for article (PubMed ID: 37208260)
1. [Limits of dose constraint definition for organs at risk specific to stereotactic radiotherapy].
Beddok A; Loi M; Rivin Del Campo E; Dumas JL; Orthuon A; Créhange G; Huguet F
Cancer Radiother; 2023 Jun; 27(4):341-348. PubMed ID: 37208260
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
Menoux I; Antoni D; Mazzara C; Labani A; Charloux A; Quoix E; Falcoz PE; Truntzer P; Noël G
Cancer Radiother; 2020 Apr; 24(2):120-127. PubMed ID: 32173269
[TBL] [Abstract][Full Text] [Related]
3. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Kong FS; Moiseenko V; Zhao J; Milano MT; Li L; Rimner A; Das S; Li XA; Miften M; Liao Z; Martel M; Bentzen SM; Jackson A; Grimm J; Marks LB; Yorke E
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):172-187. PubMed ID: 30496880
[TBL] [Abstract][Full Text] [Related]
4. [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Blais E; Pichon B; Mampuya A; Antoine M; Lagarde P; Kantor G; Breton-Callu C; Lefebvre C; Gerard M; Aamarcha A; Ozsahin M; Bourhis J; Maingon P; Troussier I; Pourel N
Cancer Radiother; 2017 Oct; 21(6-7):584-596. PubMed ID: 28886981
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
6. [Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: Limits and perspectives].
Gérard M; Jumeau R; Pichon B; Biau J; Blais E; Horion J; Noël G
Cancer Radiother; 2017 Oct; 21(6-7):636-647. PubMed ID: 28893524
[TBL] [Abstract][Full Text] [Related]
7. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
[TBL] [Abstract][Full Text] [Related]
8. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints.
Milano MT; Mihai A; Kang J; Singh DP; Verma V; Qiu H; Chen Y; Kong FS
Expert Rev Anticancer Ther; 2019 Nov; 19(11):959-969. PubMed ID: 31663398
[No Abstract] [Full Text] [Related]
10. [Radiation-induced lung toxicity predictors after stereotactic radiation therapy for non-small cell lung carcinoma stage I].
Menoux I; Le Fèvre C; Noël G; Antoni D
Cancer Radiother; 2018 Dec; 22(8):826-838. PubMed ID: 30337050
[TBL] [Abstract][Full Text] [Related]
11. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
Baker R; Han G; Sarangkasiri S; DeMarco M; Turke C; Stevens CW; Dilling TJ
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):190-5. PubMed ID: 22929858
[TBL] [Abstract][Full Text] [Related]
12. Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity With Stereotactic Body Radiation Therapy for Central Non-small Cell Lung Cancer.
Manyam BV; Verdecchia K; Videtic GMM; Zhuang T; Woody NM; Wei W; Ouyang Z; Stephans KL
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):72-78. PubMed ID: 31987965
[TBL] [Abstract][Full Text] [Related]
13. [Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum].
Goupy F; Chajon E; Castelli J; Le Prisé É; Duvergé L; Jaksic N; Vogin G; Monpetit É; Klein V; de Bosschère L; Maingon P
Cancer Radiother; 2017 Oct; 21(6-7):613-618. PubMed ID: 28886980
[TBL] [Abstract][Full Text] [Related]
14. 4π noncoplanar stereotactic body radiation therapy for centrally located or larger lung tumors.
Dong P; Lee P; Ruan D; Long T; Romeijn E; Low DA; Kupelian P; Abraham J; Yang Y; Sheng K
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):407-13. PubMed ID: 23523322
[TBL] [Abstract][Full Text] [Related]
15. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
Shang H; Pu Y; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
[TBL] [Abstract][Full Text] [Related]
16. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty.
Seco J; Panahandeh HR; Westover K; Adams J; Willers H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):354-61. PubMed ID: 21985941
[TBL] [Abstract][Full Text] [Related]
17. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
19. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis?
Parekh AD; Indelicato DJ; Hoppe BS; Vega RBM; Rotondo RL; Bradley JA
Pediatr Blood Cancer; 2021 Nov; 68(11):e29287. PubMed ID: 34398486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
